首页> 外文期刊>Cureus. >Study of Visual Function in Adult Epileptic Patients on Sodium Valproate or Carbamazepine Monotherapy
【24h】

Study of Visual Function in Adult Epileptic Patients on Sodium Valproate or Carbamazepine Monotherapy

机译:丙戊酸钠或卡马西平单药治疗成人癫痫患者视觉功能的研究

获取原文
           

摘要

Objective Epilepsy is a debilitating disease. Visual function changes have been reported and may be attributed to the epileptic changes or as a result of medication side effect. Sodium valproate and carbamazepine are both first line anti-epileptic medications used in Malaysian health care. Sodium valproate inhibits glutamate and γ-aminobutyric acid (GABA) transaminase while carbamazepine acts on the sodium channel - both are an important part of the retina.?This study aimed to compare the visual functions of epilepsy patients on carbamazepine or sodium valproate monotherapy. Design A cross-sectional study was conducted at a tertiary hospital between June 2016 and November 2018. Methods Patients with idiopathic epilepsy that fulfill the inclusion and exclusion criteria were recruited from the neurology clinic. They were divided into two groups and?underwent complete eye examinations. Visual functions such as color vision testing, contrast sensitivity, visual field and retinal nerve fiber layer measurement were subsequently performed. Statistical analysis was done using Statistical Package for the Social Science,?version 24 (SPSS Inc, Chicago, IL, USA). Results A total of 100 patients (sodium valproate: 50 patients; carbamazepine: 50 patients) were recruited for the study.?There were no statistically significant changes in anatomical or visual function between the sodium valproate?and carbamazepine group. However, patients from both groups displayed color vision defect in the blue and green axes. Changes in color vision could indicate early retina toxicity secondary to the medication. Although there were no visual field changes, patients recorded a slight reduction of mean deviation. Changes of mean deviation could be attributed to the side effect of medication or the disease process. Conclusions Epileptic patients taking sodium valproate or carbamazepine?did?not demonstrate statistically significant change in visual function.
机译:目的癫痫病是一种使人衰弱的疾病。视觉功能的变化已有报道,可能归因于癫痫的变化或药物副作用。丙戊酸钠和卡马西平都是马来西亚医疗保健中使用的一线抗癫痫药。丙戊酸钠抑制谷氨酸和γ-氨基丁酸(GABA)转氨酶,而卡马西平则作用于钠通道-两者都是视网膜的重要组成部分。本研究旨在比较癫痫患者在卡马西平或丙戊酸钠单药治疗中的视觉功能。设计在2016年6月至2018年11月期间,在一家三级医院进行了一项横断面研究。方法从神经内科诊所招募符合入选和排除标准的特发性癫痫患者。他们分为两组,并接受了全面的眼科检查。随后执行了视觉功能,例如彩色视觉测试,对比敏感度,视野和视网膜神经纤维层测量。使用“社会科学统计软件包”(第24版,SPSS Inc,美国伊利诺伊州芝加哥)进行统计分析。结果共招募了100例患者(丙戊酸钠:50例;卡马西平:50例)。丙戊酸钠和卡马西平组之间在解剖或视觉功能上没有统计学上的显着变化。但是,两组患者的蓝轴和绿轴均显示出色觉缺陷。色觉的改变可能表明药物继发的早期视网膜毒性。尽管视野没有变化,但患者的平均偏差略有降低。平均偏差的变化可能归因于药物或疾病过程的副作用。结论服用丙戊酸钠或卡马西平吗啡的癫痫患者的视觉功能未见统计学上的显着变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号